首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Prostaglandin Mediates Il-23/il-17-induced Neutrophil Migration In Inflammation By Inhibiting Il-12 And Ifny Production
【24h】

Prostaglandin Mediates Il-23/il-17-induced Neutrophil Migration In Inflammation By Inhibiting Il-12 And Ifny Production

机译:前列腺素通过抑制Il-12和Ifny的产生来介导炎症中Il-23 / il-17诱导的中性粒细胞迁移。

获取原文
获取原文并翻译 | 示例
           

摘要

IL-23/IL-17-induced neutrophil recruitment plays a pivotal role in rheumatoid arthritis (RA). However, the mechanism of the neutrophil recruitment is obscure. Here we report that prostaglandin enhances the IL-23/IL-17-induced neutrophil migration in a murine model of RA by inhibiting IL-12 and IFN y production. Methylated BSA (mBSA) and IL-23-induced neutrophil migration was inhibited by anti-IL-23 and anti-IL-17 antibodies, COX inhibitors, IL-12, or IFNy but was enhanced by prostaglandin E_2 (PGE2). IL-23-induced IL-17 production was increased by PGE2 and suppressed by GOX-inhibition or IL-12. Furthermore, COX inhibition failed to reduce IL-23-induced neutrophil migration in IL-12- or IFNγ-deficient mice. IL-17-induced neutrophil migration was not affected by COX inhibitors, IL-12, or IFNy but was inhibited by MK886 (a leukotriene synthesis inhibitor), anti-TNFα, anti-CXCL1, and anti-CXCL5 antibodies and by repertaxin (a CXCR1/2 antagonist). These treatments all inhibited mBSA- or IL-23-induced neutrophil migration. IL-17 induced neutrophil chemotaxis through a CXC chemokines-depen-dent pathway. Our results suggest that prostaglandin plays an important role in IL-23-induced neutrophil migration in arthritis by enhancing IL-17 synthesis and by inhibiting IL-12 and IFNy production. We thus provide a mechanism for the pathogenic role of the IL-23/IL-17 axis in RA and also suggest an additional mechanism of action for nonsteroidal anti-inflammatory drugs.rnantigen-induced arthritis; chemokines; cytokines; rheumatoid arthritis; Th17
机译:IL-23 / IL-17诱导的中性粒细胞募集在类风湿关节炎(RA)中起着关键作用。但是,嗜中性白细胞募集的机制尚不清楚。在这里我们报告前列腺素通过抑制IL-12和IFNγ的产生增强了RA鼠模型中IL-23 / IL-17诱导的中性粒细胞迁移。甲基化BSA(mBSA)和IL-23诱导的中性粒细胞迁移受到抗IL-23和抗IL-17抗体,COX抑制剂,IL-12或IFNγ的抑制,但被前列腺素E_2(PGE2)增强。 IL-23诱导的IL-17产生被PGE2增加,并被GOX抑制或IL-12抑制。此外,COX抑制未能减少IL-12或IFNγ缺陷小鼠中IL-23诱导的中性粒细胞迁移。 IL-17诱导的嗜中性粒细胞迁移不受COX抑制剂,IL-12或IFNγ的影响,但受到MK886(白三烯合成抑制剂),抗TNFα,抗CXCL1和抗CXCL5抗体以及repertaxin(a CXCR1 / 2拮抗剂)。这些治疗均抑制了mBSA或IL-23诱导的嗜中性粒细胞迁移。 IL-17通过CXC趋化因子依赖的途径诱导中性粒细胞趋化性。我们的结果表明,前列腺素通过增强IL-17的合成以及抑制IL-12和IFNγ的产生,在IL-23诱导的关节炎中性粒细胞迁移中起重要作用。因此,我们提供了IL-23 / IL-17轴在RA中的致病作用的机制,并且还提出了针对非甾体类抗炎药的另一种作用机制。趋化因子细胞因子类风湿关节炎; Th17

著录项

  • 来源
  • 作者单位

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Laboratory of Pharmacology, National Institute for Research in the Amazon (INPA), Manaus, Amazonas 69060-001, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Division of Immunology, Infection and Inflammation, Faculty of Medicine, Glasgow Biomedical Research Centre, University of Glasgow, Glascow G12 8TA, United Kingdom;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

    Division of Immunology, Infection and Inflammation, Faculty of Medicine, Glasgow Biomedical Research Centre, University of Glasgow, Glascow G12 8TA, United Kingdom;

    Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo 14.049-900, Brazil;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号